April 3, 2018 / 4:40 PM / 4 months ago

BRIEF-Inventiva Announces U.S. Phase II Investigator-Initiated Study With Lanifibranor

April 3 (Reuters) - INVENTIVA SA:

* ANNOUNCES A U.S. PHASE II INVESTIGATOR-INITIATED STUDY WITH LANIFIBRANOR ON NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES

* TRIAL SHOULD BEGIN IN Q2/Q3 2018 DEPENDING ON FDA APPROVAL OF LANIFIBRANOR IND FILING Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below